Induction of autoantibody production but not autoimmune disease in HEL transgenic mice vaccinated with HEL in combination with CpG or control oligodeoxynucleotides
- 1 June 2004
- Vol. 22 (20) , 2641-2650
- https://doi.org/10.1016/j.vaccine.2003.11.055
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP119) formulated in oil-based MontanidesVaccine, 2003
- Natural selection of tumor variants in the generation of “tumor escape” phenotypesNature Immunology, 2002
- Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapyEuropean Journal of Immunology, 2002
- Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complexHepatology, 2002
- A role for Toll in autoimmunityNature Immunology, 2002
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- CpG Oligodeoxynucleotides with Hepatitis B Surface Antigen (HBsAg) for Vaccination in HBsAg-Transgenic MiceJournal of Virology, 2001
- Rescue of self-reactive B cells by provision of T cell helpin vivoEuropean Journal of Immunology, 1998
- CpG‐containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvantsEuropean Journal of Immunology, 1997
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995